Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.

Gallium-68 from GalliaPharm is used for the preparation of diagnostic imaging drugs in Positron Emission Tomography (PET).

News | PET Imaging

Eckert & Ziegler Extends Gallium-68 Generator Portfolio in the United States

September 3, 2021 — Eckert & Ziegler Radiopharma GmbH has successfully submitted an amendment to their Drug Master File ...

September 03, 2021

Wisconsin-based company will help secure U.S. supply of Mo-99 used in 40,000 medical procedures daily, promote nuclear nonproliferation

News | Nuclear Imaging

NNSA Awards $37 Million to Promote U.S. Production of Critical Medical Isotope

August 27, 2021 — The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) issued two cooperative ...

August 27, 2021

ASTRO’s 63rd Annual Meeting is scheduled to take place as an in-person meeting October 24-27 in Chicago, but be sure to bring along your masks

News | ASTRO

Mask Up at ASTRO21

August 11, 2021 — ASTRO announced that it is facilitating measures that seek to ensure optimal health and sanitary ...

August 11, 2021

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

Cerium-134 can be targeted to provide an imaging analogue for two different therapy isotopes, actinium-225 and thorium-227. This helps scientists understand these therapy isotopes and develop new treatments. Image courtesy of Donald Montoya, Los Alamos National Laboratory

News | PET Imaging

New Imaging Isotope Meets Promising Therapy Isotopes

August 6, 2021 — A multidisciplinary team has demonstrated the production, purification, and potential application of ...

August 06, 2021

PET, PET imaging, PET-CT, FDG PET, PET cancer assessment, pet scanner, nuclear imaging, molecular imaging

News | PET-CT

The PET/CT Systems Market to Gel Well with Technological Upgrades

August 4, 2021 — PET/CT systems are expected to continue to incorporate the highest clinical performance of PET as well ...

August 04, 2021

The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR), along with physicians and patient organizations, supports the introduction of H.R. 4479, the “Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021” by Congressmen Scott Peters (D-CA), Bobby Rush (D-IL), Neal Dunn (R-FL) and Greg Murphy (R-NC).

News | Nuclear Imaging

Council on Radionuclides and Radiopharmaceuticals Supports the FIND Act of 2021

August 4, 2021 — The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR), along with physicians and patient ...

August 04, 2021

Positrigo reports completion of the ExploreBPET clinical study, using the novel investigational medical device BPET for imaging of the human brain

News | PET Imaging

Successful Exploratory Clinical Study with Ultracompact Brain PET Sevice

August 3, 2021 — Positrigo, a company developing nuclear medical imaging devices that advance functional imaging ...

August 03, 2021

News | Molecular Imaging

Molecular Imaging Market to Reach $6.18 Billion

August 2, 2021 — The global molecular imaging market was evaluated at $4.199 billion for the year 2019 growing at a CAGR ...

August 02, 2021

The FLASH Effect significantly improves the therapeutic ratio for curing cancer

News | Radiation Oncology

IntraOp Announces First Patients Enrolled in FLASH Clinical Trial

July 28, 2021 — IntraOp Medical Corporation announced that Lausanne University Hospital (CHUV, Switzerland) enrolled the ...

July 28, 2021

News | PET Imaging

Swiss Nuclear Medical Imaging Company Gets Financial Boost

July 16, 2021 — Positrigo, a company developing nuclear medical imaging devices to advance functional imaging, today ...

July 16, 2021

American Society for Radiation Oncology (ASTRO) to host in-person Annual Meeting in Chicago, October 24-27

News | ASTRO

ASTRO 2021 Announces its October Event is In-person

July 8, 2021 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 63rd Annual Meeting ...

July 08, 2021

Aduhelm should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia

News | PET Imaging

FDA Approves Updated Aduhelm Prescribing Information

July 8, 2021 — Biogen and Eisai Co., Ltd. announced the U.S. Food and Drug Administration (FDA) has approved an updated ...

July 08, 2021

The U.S. Food and Drug Administration (FDA) approved a new imaging agent for detection of prostate cancer, providing a more effective imaging approach to detect the spread of cancer to other parts of the body. Piflufolastat F-18 injection is the first fluorinated prostate-specific membrane antigen (PSMA) agent approved by the FDA and also the first commercially available PSMA PET imaging agent.

News | PET Imaging

FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer

June 28, 2021 — The U.S. Food and Drug Administration (FDA) approved a new imaging agent for detection of prostate ...

June 28, 2021

GE Healthcare also recently announced Xeleris V, a new virtualized, flexible AI-powered solution that provides clinicians secure access to data from anywhere – helping them make personalized care decisions and treatment recommendations that are at the heart of precision health.

News | Nuclear Imaging

GE Healthcare Advances Precision Health & Theranostics With New Products & Solutions

June 22, 2021 — At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare ...

June 22, 2021

Master Supply Agreement encompasses clinical development and commercial supply for Clarity’s Cu-67-based candidates to treat neuroblastoma, breast and prostate cancers, among others

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Enters U.S. Supply Agreement for Commercial Supply of Therapeutic Radioisotope Copper-67 (Cu-67)

June 22, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

June 22, 2021

A novel positron emission tomography (PET) radiotracer has been shown to effectively measure increases in brain tau—a distinguishing characteristic of Alzheimer’s disease—before any symptoms of the disease are observed.

News | PET Imaging

New PET Tracer Detects Hallmark of Alzheimer’s Disease Years Before Symptoms Emerge

June 16, 2021 — A novel positron emission tomography (PET) radiotracer has been shown to effectively measure increases ...

June 16, 2021

SNMMI's Image of the Year is a detailed depiction of areas of cognitive impairment, neurological symptoms and comparison of impairment over a six-month time frame

News | PET Imaging

SNMMI Image of the Year: PET Imaging Measures Cognitive Impairment in COVID-19 Patients

June 16, 2021 — The effects of COVID-19 on the brain can be accurately measured with positron emission tomography (PET) ...

June 16, 2021

A new imaging technique has the potential to detect neurological disorders — such as Alzheimer's disease — at their earliest stages, enabling physicians to diagnose and treat patients more quickly. Termed super-resolution, the imaging methodology combines position emission tomography (PET) with an external motion tracking device to create highly detailed images of the brain.

News | PET Imaging

New Super-resolution Technique Allows for More Detailed Brain Imaging

June 14, 2021 — A new imaging technique has the potential to detect neurological disorders — such as Alzheimer's disease ...

June 14, 2021

Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

News | PET-CT

Radiotracer Effective for Detection and Assessment of Lung Fibrosis

June 14, 2021 — Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) ...

June 14, 2021

Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.

News | SPECT Imaging

Deep Learning with SPECT Accurately Predicts Major Adverse Cardiac Events

June 14, 2021 — An advanced artificial intelligence technique known as deep learning can predict major adverse cardiac ...

June 14, 2021